Douglas G. Cole Denali Therapeutics Inc. (DNLI) insider trading activity
Douglas G. Cole is Director of Denali Therapeutics Inc.. Currently has a direct ownership of 26,564 shares of DNLI, which is worth approximately $551,999. The most recent transaction as insider was on Jun 01, 2023, when has been sold 4,216 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
26.6K
0%
3M change
0%
12M change
Total Value Held
$551,999
Douglas G. Cole Transaction History
Also insider at
DGC
Douglas G. Cole
Director
Cambridge, MA